ID24468A - 2-asilaminopropanamina sebagai antagonis reseptor tachykinin - Google Patents

2-asilaminopropanamina sebagai antagonis reseptor tachykinin

Info

Publication number
ID24468A
ID24468A IDW20000220A ID20000220A ID24468A ID 24468 A ID24468 A ID 24468A ID W20000220 A IDW20000220 A ID W20000220A ID 20000220 A ID20000220 A ID 20000220A ID 24468 A ID24468 A ID 24468A
Authority
ID
Indonesia
Prior art keywords
acylaminopropanamina
receptor antagonists
tachykinin receptor
tachykinin
antagonists
Prior art date
Application number
IDW20000220A
Other languages
English (en)
Indonesian (id)
Inventor
James Erwin Fritz
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ID24468A publication Critical patent/ID24468A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Indole Compounds (AREA)
IDW20000220A 1997-08-06 1998-08-06 2-asilaminopropanamina sebagai antagonis reseptor tachykinin ID24468A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5499797P 1997-08-06 1997-08-06

Publications (1)

Publication Number Publication Date
ID24468A true ID24468A (id) 2000-07-20

Family

ID=21994906

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000220A ID24468A (id) 1997-08-06 1998-08-06 2-asilaminopropanamina sebagai antagonis reseptor tachykinin

Country Status (17)

Country Link
US (1) US6358994B1 (xx)
EP (1) EP1005454A4 (xx)
JP (1) JP2001512715A (xx)
KR (1) KR20010022581A (xx)
CN (1) CN1272842A (xx)
AU (1) AU8693398A (xx)
BR (1) BR9811821A (xx)
CA (1) CA2298701A1 (xx)
EA (1) EA200000198A1 (xx)
HR (1) HRP20000065A2 (xx)
HU (1) HUP0002929A3 (xx)
ID (1) ID24468A (xx)
IL (1) IL134301A0 (xx)
NO (1) NO20000519L (xx)
PL (1) PL338453A1 (xx)
TR (1) TR200000291T2 (xx)
WO (1) WO1999007677A1 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007681A1 (en) * 1997-08-06 1999-02-18 Eli Lilly And Company 2-acylaminopropanamines as tachykinin receptor antagonists
JP4146730B2 (ja) * 2001-04-23 2008-09-10 エフ.ホフマン−ラ ロシュ アーゲー 良性前立腺肥大に対するnk−1受容体拮抗薬の使用
AR039329A1 (es) 2002-04-26 2005-02-16 Lilly Co Eli Derivados de triazol, antagonistas de receptor de taquicinina
PT1501808E (pt) * 2002-04-26 2008-09-26 Lilly Co Eli Antagonistas de receptores taquiquininas
AR050253A1 (es) 2004-06-24 2006-10-11 Smithkline Beecham Corp Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
UA99699C2 (ru) * 2005-06-30 2012-09-25 Смитклайн Бичам Корпорейшн Производные индолкарбоксамида и фармацевтическая композиция, которая их содержит
EP2129381A1 (en) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
PE20081889A1 (es) 2007-03-23 2009-03-05 Smithkline Beecham Corp Indol carboxamidas como inhibidores de ikk2
US8354539B2 (en) 2009-03-10 2013-01-15 Glaxo Group Limited Indole derivatives as IKK2 inhibitors
WO2011104307A2 (en) * 2010-02-25 2011-09-01 Graffinity Pharmaceuticals Gmbh Ligands for antibody purification by affinity chromatography
CN105906608B (zh) * 2016-05-03 2018-10-19 中山大学 8-氨基喹啉-松果体素杂联体及其药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1340588C (en) 1988-06-13 1999-06-08 Balraj Krishan Handa Amino acid derivatives
US5278316A (en) * 1989-06-29 1994-01-11 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives
WO1994004494A1 (en) * 1992-08-13 1994-03-03 Warner-Lambert Company Tachykinin antagonists
EP1082959A1 (en) 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonists for the treatment of depression
US5328927A (en) * 1992-03-03 1994-07-12 Merck Sharpe & Dohme, Ltd. Hetercyclic compounds, processes for their preparation and pharmaceutical compositions containing them
US5612336A (en) * 1992-07-13 1997-03-18 Merck, Sharp & Dohme Ltd. Heterocyclic amide derivatives as tachykinin antagonists
US5554627A (en) 1992-10-30 1996-09-10 Merck, Sharp & Dohme Ltd. Tachykinin antagonists
US6403577B1 (en) * 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
US5491140A (en) 1994-06-30 1996-02-13 Eli Lilly And Company Naphthyl tachykinin receptor antagonists to treat physiological conditions
BR9508375A (pt) * 1994-07-12 1997-10-28 Lilly Co Eli Antagonista de receptor de taquicinina heterociclica

Also Published As

Publication number Publication date
JP2001512715A (ja) 2001-08-28
IL134301A0 (en) 2001-04-30
EP1005454A4 (en) 2003-01-15
EP1005454A1 (en) 2000-06-07
EA200000198A1 (ru) 2000-10-30
BR9811821A (pt) 2000-08-15
AU8693398A (en) 1999-03-01
CA2298701A1 (en) 1999-02-18
US6358994B1 (en) 2002-03-19
NO20000519D0 (no) 2000-02-01
HUP0002929A3 (en) 2002-01-28
NO20000519L (no) 2000-03-31
CN1272842A (zh) 2000-11-08
HRP20000065A2 (en) 2001-04-30
TR200000291T2 (tr) 2000-07-21
HUP0002929A2 (hu) 2001-10-28
PL338453A1 (en) 2000-11-06
KR20010022581A (ko) 2001-03-26
WO1999007677A1 (en) 1999-02-18

Similar Documents

Publication Publication Date Title
ID19623A (id) Antagonis reseptor vitronektin
DE69812096T2 (de) Neuropeptid y rezeptorantagonisten
NO951613D0 (no) Ikke-peptidyl tachykinin reseptorantagonister
ID18003A (id) Antagonis muskarinik
DK1009732T3 (da) 1-Amino-alkylcyclohexan NMDA receptor antagonister
ID16742A (id) Antagonis reseptor endotelin
ID26223A (id) Antagonis reseptor vitronektin
ID24726A (id) Antagonis-antagonis reseptor trombin
ID24162A (id) Antagonis-antagonis reseptor vitronektin
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
DE69626220T2 (de) 3-azetidinylalkylpiperidine oder -pyrrolidine als tachykinin antagonisten
ID26665A (id) Antagonis vla-4
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID28811A (id) Antagonis reseptor vitronektin
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
DE69732715D1 (de) Tachykinin antagoniste
ID24309A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID26508A (id) Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
ID22978A (id) Antagonis reseptor endotelin
DK0964867T3 (da) Tachykininantagonister
GB9702922D0 (en) Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
ID25461A (id) Turunan 2-ariletil-(piperidin-4-ilmetil)amina sebagai antagonis reseptor muskarinik
GB9702834D0 (en) Fibrinogen receptor antagonists
EP1001777A4 (en) Fibrinogen Receptor Antagonists